Predictors of Non-response and Loss of Response in IBD Patients Treated With Anti-TNF

Patient Attitudes and Preferences for Outcomes of Inflammatory Bowel Disease Therapeutics

NCT02316678 ·Status: COMPLETED

Anti-tumor Necrosis Factor in Patients With Ulcerative Colitis in Clinical Remission: to Continue or Not?

NCT03011268 ·Status: COMPLETED ·Phase: NA

Predictors of Prognosis in IBD Patients

NCT05653011 ·Status: RECRUITING

SSAT 054: Non Genetic Factors in the Pathogenesis of IBD in Twins

NCT02383953 ·Status: UNKNOWN

Surgically Resected Crohn's Disease Patients: Prognostic Factors for Re-operation and New Score Building

NCT03150238 ·Status: UNKNOWN

A Prospective Study on the Incidence and Risk Factors Related to Infection in Patients With Inflammatory Bowel Disease

NCT02904590 ·Status: COMPLETED

Family Members At INcreased-risk for Developing Inflammatory Bowel Disease

NCT06655415 ·Status: RECRUITING

Prevalence of Lymphoma in IBD

NCT00577538 ·Status: COMPLETED

Anti-pneumococcal Vaccine Strategy in Patients Treated With Immunosuppressants or Biotherapies for CIBD

NCT02255227 ·Status: TERMINATED ·Phase: PHASE2

Assessment of the Response to the Complete Vaccination Guidelines Against Sars-cov2

NCT05153850 ·Status: UNKNOWN

Can we Rely on HLA to Predict Resistance to Biological Therapy in IBD Patients

NCT05040854 ·Status: UNKNOWN

the Prevalence of Chronic Rhinosinusitis Associated With Inflammatory Bowel Disease and Association With Biomarkers of Epithelial Barrier Damage

NCT06149949 ·Status: NOT_YET_RECRUITING

A Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease

NCT00055523 ·Status: COMPLETED ·Phase: PHASE2

Predictive Factors of ANTI-TNF Response in Luminal Crohn's Disease Complicated by Abscess

NCT02856763 ·Status: COMPLETED

Clinical Efficacy of TNFa Kinoid in Crohn's Disease Patients

NCT01291810 ·Status: COMPLETED ·Phase: PHASE2

Medico-economic Evaluation of the Therapeutic Drug Monitoring of Anti-TNF-α Agents in Inflammatory Bowel Diseases

NCT02508012 ·Status: COMPLETED ·Phase: NA

Serologic Markers for Inflammatory Bowel Disease During Clinical Forms With Weak or Strong Evolution Capacities

NCT01216514 ·Status: COMPLETED

Interactions Between Immune Cells of Intestinal Mucosa or Peripheral Blood With the Extracellular Matrix in Inflammatory Bowel Disease (IBD)

NCT00915044 ·Status: UNKNOWN

Evaluation of the Safety, Tolerability, and Efficacy of MDGN-002 in Adults With Moderate to Severe Active Crohn's Disease or Ulcerative Colitis

NCT03169894 ·Status: TERMINATED ·Phase: PHASE1

Prevalence, Characteristics, Management, and Outcomes of Difficult-to-treat Inflammatory Bowel Disease

NCT06551194 ·Status: RECRUITING

Bologna IBD Markers

NCT02580864 ·Status: COMPLETED

Immunological Characteristics of Preclinical IBD

NCT05698745 ·Status: RECRUITING

Personalising Anti-TNF Therapy in Crohns Disease (PANTS)

NCT03088449 ·Status: UNKNOWN

A Retrospective Observational Study to Assess the Impact of Co-morbidities on Treatment Response in Inflammatory Bowel Disease

NCT02861118 ·Status: COMPLETED

Influence of HLA-DQA1*05 Genotype in Adults With Anti-TNF Treatment With Proactive Therapeutic Drug Monitoring.

NCT05986903 ·Status: UNKNOWN